NEUROTARGETS
NeuroTargets is a biotechnology company that researches and develops drugs for the treatment of neurological diseases. The company is developing drugs focusing on nerve injury-related disease indications including neuropathic pain, inflammatory pain, peripheral neuropathy, and brain injury and stroke.
NEUROTARGETS
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
1999-01-01
Address:
Guildford, Surrey, United Kingdom
Country:
United Kingdom
Status:
Active
Contact:
+44 1483 295 429
Similar Organizations
Biosearch Life
e is a biotechnology company that develops and manufactures products through the innovation of natural ingredients.
Inoser
Inoser is a biotechnology company that engages in performing analytical tests to produce oenological products.
Juvabis
Juvabis is a startup company that designs next-generation aminoglycoside antibiotics that withstand mechanisms of bacterial drug-resistance.
Xellera Therapeutics
Xellera Therapeutics is a biotechnology company discovers and develops therapeutic and regenerative medicine for the treatment of diseases.
More informations about "NeuroTargets"
NeuroTargets - Crunchbase Company Profile & Funding
NeuroTargets is a biotechnology company that researches and develops drugs for the treatment of neurological diseases. The company is developing drugs focusing on nerve injury-related …See details»
NeuroTargets - VentureRadar
NeuroTargets Ltd is an innovative biopharmaceutical company that uses novel genes for the development of drug targets. Active in the fields of... ... Find out more about NeuroTargets …See details»
2004: NeuroTargets alliance | News and features - University of …
Aug 11, 2004 · NeuroTargets Ltd, a discovery-led biotechnology company ‘spun-out’ from the University of Bristol, has formed an exciting new alliance with BioFocus plc, a world leader in …See details»
Neurotargets - Products, Competitors, Financials, Employees ...
Developer of therapeutics for the treatment of neurological diseases. The company develops drugs which target the small GTP-binding protein Rho and the neuropeptide galanin.See details»
NeuroTargets Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Explore NeuroTargets Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
NeuroTargets - Tech Stack, Apps, Patents & Trademarks
NeuroTargets is a biotechnology company that researches and develops drugs for the treatment of neurological diseases.See details»
NeuroTargets - Crunchbase
NeuroTargets is a biotechnology company that researches and develops drugs for the treatment of neurological diseases.See details»
Neurotargeting - LinkedIn
Neurotargeting’s mission is to organize the world’s neurological information and make it useful for patients, physicians, insurance and device or drug companies.See details»
NeuroTargets Fly Lab » Department of Neurology » …
The NeuroTargets Fly Lab focuses on the development and application of new technologies to define the molecular pathways leading to neurodegeneration and to identify potential therapeutic targets. To do so, we utilize the fruit fly …See details»
Research programme: nerve injury therapeutics
Galapagos (formerly BioFocus) and NeuroTargets Limited were collaborating on a research project to develop drug candidates that bind a specific receptorSee details»
International Neuroscience Organizations - BrainFacts
Nov 14, 2018 · Neuroscientists around the globe are working to unlock the mysteries of the human brain, supported by public and private science investment. Learn more about regional …See details»
Tackling the growing burden of neurological disease
Jan 24, 2024 · In May 2022, the World Health Organization adopted the Intersectoral global action plan on epilepsy and other neurological disorders 2022-2031 (IGAP), which aims to improve …See details»
Developing precision neurotherapeutics takes patients - Nature
With a drug discovery platform built around patient-derived induced pluripotent stem cells and multi-omics, PurMinds NeuroPharma is de-risking the path to targeted brain therapeutics.See details»
NIH Scientists Redesign Neurons to Enable Targeted Therapies
Mar 17, 2021 · To find their way through the maze of neurons and other cells that make up the brain, scientists use a technology called ‘chemogenetics’ that allows them to target only the …See details»
Neurotargeting LLC - Crunchbase Company Profile & Funding
Neurotargeting, LLC emerged from more than a decade of research performed at Vanderbilt University and supported by NIH funding focused on solving such issues. From this research …See details»
Neurotech Entrepreneurship to Validate… | Ontario Brain Institute
Epineuron Technologies, Inc., a bioelectronic medicine company, announced the completion of a financing round to support production development and clinical validation for its …See details»
Mapping neurotransmitter systems to the structural and functional ...
Oct 27, 2022 · This work demonstrates how chemoarchitecture shapes brain structure and function, providing a new direction for studying multi-scale brain organization.See details»
CNS and Neurodegenerative Targets - Discovery On Target
Driven by an improving understanding of CNS disease biology and the emergence of new mechanisms and targets, Cambridge Healthtech Institute’s CNS and Neurodegenerative …See details»
The Neurorights Foundation
Mar 30, 2024 · We are working to incorporate five Neuro-rights that have been identified as critical into international human rights law, national legal and regulatory frameworks, and ethical …See details»
Improving cognition with noninvasive, personalized treatments
Novel therapeutic interventions capable of providing rapid, personalized and sustainable improvements with minimal side effects are urgently needed, and one class of tools that has …See details»